188 related articles for article (PubMed ID: 15478662)
1. [Case of ulcerative colitis induced by mesalazine with acute aggravated colitis-like symptoms].
Inatsuchi S; Nakajima T; Yoshio Y; Entani A; Okada K
Nihon Shokakibyo Gakkai Zasshi; 2004 Sep; 101(9):989-92. PubMed ID: 15478662
[No Abstract] [Full Text] [Related]
2. [A case of left-sided ulcerative colitis successfully treated with mesalazine enema but not steroid suppository].
Yamamoto S; Miyata Y; Kato J; Hasuike S; Ideguchi T; Minami H; Hori T; Hirono S; Hayashi K; Tsubouchi H
Nihon Shokakibyo Gakkai Zasshi; 2000 Jul; 97(7):910-3. PubMed ID: 10934875
[No Abstract] [Full Text] [Related]
3. Mesalazine-induced multi-organ hypersensitivity.
Sposato B; Allegri MP; Riccardi MP; Chigiotti S; Nencioni C; Ricciardi B; Carli T; Cresti A; Perari MG; Migliorini MG; Toti M
Clin Drug Investig; 2010; 30(6):413-7. PubMed ID: 20441247
[TBL] [Abstract][Full Text] [Related]
4. What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?
Riley SA
Gut; 1998 Jun; 42(6):761-3. PubMed ID: 9691909
[No Abstract] [Full Text] [Related]
5. Recurrence of myocarditis after mesalazine treatment for ulcerative colitis: a case report.
Sabatini T; Filippini A; Nicosia F; Preti S; Bertoli M
Inflamm Bowel Dis; 2013 Mar; 19(3):E46-8. PubMed ID: 22517473
[No Abstract] [Full Text] [Related]
6. Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.
Murphy SJ; Mayer L; Abreu MT
J Clin Gastroenterol; 2011 Jan; 45(1):83-4. PubMed ID: 20535023
[No Abstract] [Full Text] [Related]
7. Efficacy and tolerability of mesalazine foam enema (Salofalk foam) for distal ulcerative colitis: a double-blind, randomized, placebo-controlled study.
Pokrotnieks J; Marlicz K; Paradowski L; Margus B; Zaborowski P; Greinwald R
Aliment Pharmacol Ther; 2000 Sep; 14(9):1191-8. PubMed ID: 10971236
[TBL] [Abstract][Full Text] [Related]
8. Recurrent pericarditis due to mesalamine hypersensitivity: a pediatric case report and review of the literature.
Sentongo TA; Piccoli DA
J Pediatr Gastroenterol Nutr; 1998 Sep; 27(3):344-7. PubMed ID: 9740210
[No Abstract] [Full Text] [Related]
9. High-dose mesalazine treatment for ulcerative colitis patients who relapse under low-dose maintenance therapy.
Yamamoto T; Umegae S; Matsumoto K
Dig Liver Dis; 2011 May; 43(5):386-90. PubMed ID: 21195041
[TBL] [Abstract][Full Text] [Related]
10. Mesalazine allergy in a boy with ulcerative colitis: clinical usefulness of mucosal biopsy criteria.
Wada S; Kumagai H; Yokoyama K; Ito T; Miyauchi A; Sakamoto S; Imagawa T; Tulyeu J; Tanaka M; Yamagata T
Clin J Gastroenterol; 2016 Oct; 9(5):302-5. PubMed ID: 27503129
[TBL] [Abstract][Full Text] [Related]
11. Mesalazine-induced interstitial nephritis in a patient with ulcerative colitis.
Gorospe EC; Leggett CL
BMJ Case Rep; 2012 Feb; 2012():. PubMed ID: 22665567
[No Abstract] [Full Text] [Related]
12. A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis.
Malchow H; Gertz B;
Aliment Pharmacol Ther; 2002 Mar; 16(3):415-23. PubMed ID: 11876694
[TBL] [Abstract][Full Text] [Related]
13. Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis.
Tsuboi R; Matsumoto S; Miyatani H; Mashima H
Intern Med; 2019 Mar; 58(5):649-654. PubMed ID: 30333413
[TBL] [Abstract][Full Text] [Related]
14. Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.
Marteau P; Probert CS; Lindgren S; Gassul M; Tan TG; Dignass A; Befrits R; Midhagen G; Rademaker J; Foldager M
Gut; 2005 Jul; 54(7):960-5. PubMed ID: 15951542
[TBL] [Abstract][Full Text] [Related]
15. Myopericarditis and mitral insufficiency associated with ulcerative colitis treated with mesalazine.
García-Morán S; Sáez-Royuela F; Pérez-Alvarez JC; Gento E; Téllez J
Inflamm Bowel Dis; 2006 Apr; 12(4):334-5. PubMed ID: 16633055
[No Abstract] [Full Text] [Related]
16. [Two cases of drug-induced intrathoracic lesions caused by mesalazine in patients with ulcerative colitis].
Machida H; Shinohara T; Hatakeyama N; Inayama M; Hosokawa E; Ogushi F
Nihon Kokyuki Gakkai Zasshi; 2011 Jul; 49(7):538-42. PubMed ID: 21842693
[TBL] [Abstract][Full Text] [Related]
17. Mesalazine-induced myopericarditis in a patient with ulcerative colitis.
Doganay L; Akinci B; Pekel N; Simsek I; Akpinar H
Int J Colorectal Dis; 2006 Mar; 21(2):199-200. PubMed ID: 15726390
[No Abstract] [Full Text] [Related]
18. Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications.
Schroeder KW
Scand J Gastroenterol Suppl; 2002; (236):42-7. PubMed ID: 12408503
[TBL] [Abstract][Full Text] [Related]
19. [Interstitial nephritis associated with mesalazine therapy].
Vuotila M; Ikäheimo R; Pietiläinen T
Duodecim; 2003; 119(20):1978-82. PubMed ID: 14640003
[No Abstract] [Full Text] [Related]
20. Mesalamine hypersensitivity and Kounis syndrome in a pediatric ulcerative colitis patient.
Kounis GN; Kouni SA; Hahalis G; Kounis NG
World J Gastroenterol; 2008 Dec; 14(46):7141-2. PubMed ID: 19084925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
